# A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC

> **NCT02669147** · — · COMPLETED · sponsor: **Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan** · enrollment: 160 (actual)

## Conditions studied

- Castration Resistant Prostate Cancer (CRPC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02669147
- **Lead sponsor:** Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-26
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2022-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02669147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02669147, "A Study to Determine Enzalutamide Long-term Safety and Efficacy After Anti-androgen Therapy for CRPC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02669147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*